ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 177391 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 177391; 2) Community: the network communities that were significantly associated with the response to NSC 177391; 3) Molecule: the relationships between components within communities and NSC 177391; 4) MDR: the compounds that were significantly associated with the NSC 177391.

NSC Compound Enrichment Correlation
NSC 328186 3',4',5'-trimethoxy-3-hydroxy flavone 0.00456325077253399 0.056444056
NSC 640506 1,4-Butanediamine, N-[4-(ethylamino)butyl]-N'-[4-[[4-(ethylamino)butyl]amino]butyl]-, pentahydrochloride 0.00593538156800935 0.064546201
NSC 666871 Null 0.00593538156800935 -0.31537793
NSC 669229 2-trans-n-buten-1-yl-estradiol 0.00593538156800935 -0.014366878
NSC 693167 Null 0.00593538156800935 -0.25416143
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.00593538156800935 0.10034221
NSC 610459 Camptothecin Derivative 0.00663743932906076 -0.20332209
NSC 681639 Camptothecin Derivative 0.00663743932906076 -0.18714597
NSC 111533 Methoxycamptothecin 0.00663743932906085 -0.17730619
NSC 144303 4H-Thiopyran-4-one, tetrahydro-3,5-bis[(4-nitrophenyl)methylene]-, 1,1-dioxide 0.00904157676870188 -0.032446475
Total:19  Current:2    [First] [Prev] [Next] [Last]